Alison L. Hannah - 08 Jul 2026 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Reporting relationship: EVP, Chief Medical Officer
Issuer ticker: RIGL
Reported as of: 08 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jul 2026, 21:53:28 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Raymond Furey (Attorney-in-Fact)

Key filing fact

Alison L. Hannah filed Form 4 for RIGEL PHARMACEUTICALS INC (RIGL) on 10 Jul 2026.

Key facts

This page summarizes Alison L. Hannah's Form 4 filing for RIGEL PHARMACEUTICALS INC (RIGL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jul 2026, 21:53.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001645600 Primary reporting owner

HANNAH ALISON L.

Relationship: EVP, Chief Medical Officer
Address: RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO
Signature: /s/ Raymond Furey (Attorney-in-Fact)
Signature date: 10 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RIGL transaction

Common Stock

Award

Transaction value
Shares: +24,400
Change %: +230%
Price: $0.000000^*
Shares after: 35,025
Date: 08 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from July 8, 2026, with the first annual vest occurring on July 8, 2027.

Footnote F2

Amount has been adjusted to reflect the cancellation of 5,750 restricted stock units for no consideration, which is exempt from Section 16 pursuant to Rule 16b-6(d) and Rule 16a-4(d) promulgated under the Securities Exchange Act of 1934, as amended.